CinCor Pharma
Cincinnati, US · Founded 2018 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
MD
Marc de GaridelExecutive Officer, Director
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$142.9MraisedOct 2021 · 22 investors · BiotechnologyRule 506(b)
▶$142.9MraisedOct 2021 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marc de GaridelExecutive Officer, Director
- Offering amount
- $142.9M
- Amount sold
- $142.9M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.